Skip to main content
. 2014 Mar 1;189(5):576–585. doi: 10.1164/rccm.201309-1575OC

Table 1:

Demographics and Comorbidities Associated with Clinical Outcomes in Bronchiectasis

  N 4-yr Mortality Rate Hospitalizations Annual Exacerbation Frequency SGRQ
Age, yr          
 <30 (ref) 17 0 (0%) 2 (11.8%) 1.56 (1.4) 26.0 (22.2)
 30–49 50 1 (2%) 11 (22.0%) 1.74 (1.4) 41.4 (21.6)
 50–69 268 11 (4.1%) 82 (30.6%) 1.94 (1.4) 42.3 (23.9)
 70–79 203 29 (14.3%) 64 (31.5%) 1.78 (1.4) 45.8 (22.8)
 80+ 68 22 (32.4%) 30 (44.1%) 1.73 (1.2) 46.5 (22.1)
P value   <0.0001 0.03 0.5 0.008
Sex          
 Male (ref) 243 29 (11.9%) 73 (30.0%) 1.85 (1.42) 42.2 (24.0)
 Female 365 33 (9.0%) 116 (31.8%) 1.82 (1.32) 44.0 (22.7)
P value   0.2 0.6 0.8 0.4
BMI          
 <18.5 42 13 (31.0%) 22 (52.4%) 2.44 (1.9) 47.5 (27.4)
 18.5–25 (ref) 227 21 (9.1%) 71 (30.9%) 1.84 (1.3) 40.8 (22.2)
 25–30 214 15 (7.0%) 55 (25.7%) 1.62 (1.2) 40.2 (21.7)
 30+ 125 13 (10.4%) 41 (32.8%) 1.93 (1.5) 50.7 (24.8)
P value   <0.0001 0.008 0.003 <0.0001
Underlying cause          
 Idiopathic/postinfective (ref) 386 39 (10.1%) 110 (28.5%) 1.89 (1.4) 42.0 (23.3)
 Previous TB 82 11 (13.4%) 33 (40.2%) 1.50 (1.0) 41.8 (25.6)
 Previous ABPA 49 3 (6.1%) 20 (40.8%) 1.64 (1.1) 45.8 (18.4)
 Rheumatoid arthritis 44 5 (11.4%) 13 (29.5%) 1.98 (1.6) 46.8 (23.0)
 Inflammatory bowel disease 14 2 (14.3%) 6 (42.9%) 1.70 (1.4) 54.3 (19.5)
 Others 33 2 (6.1%) 7 (21.2%) 2.11 (1.7) 49.6 (24.0)
P value   0.7 0.1 0.1 0.1
Comorbidities          
 Chronic cardiac disease 139 27 (19.4%)* 41 (29.5%) 1.70 (1.3) 46.1 (22.4)
 Cerebrovascular disease 63 16 (25.4%) 35 (55.6%)* 1.73 (1.4) 48.0 (23.1)
 Chronic renal failure 36 6 (16.7%) 14 (38.9%) 1.40 (1.1) 44.3 (21.2)
 Diabetes mellitus 67 6 (9.0%) 13 (19.4%) 1.81 (1.3) 44.9 (23.6)
 Current smokers 42 4 (9.5%) 18 (42.9%) 2.12 (1.5) 42.4 (20.4)

Definition of abbreviations: ABPA = allergic bronchopulmonary aspergillosis; BMI = body mass index; ref = reference; SGRQ = St. George's Respiratory Questionnaire; TB = tuberculosis.

P values refer to comparisons between groups using chi-squared test (categorical data) or analysis of variance (continuous data).

*

P < 0.05, comparisons made with patients without this comorbidity. All other relationships not statistically significant.